Drug Type Hematopoietic stem cell therapy |
Synonyms BD311 |
Target |
Action stimulants |
Mechanism VEGF stimulants(Vascular endothelial growth factor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wet age-related macular degeneration | Phase 2 | China | 11 Aug 2022 | |
Diabetic macular oedema | Phase 1 | China | 25 Nov 2021 | |
Retinal Vein Occlusion | Phase 1 | China | 25 Nov 2021 |